American Society of Nephrology Kidney Week 2014

American Society of Nephrology Kidney Week 2014 | Kidney Week 2014

Billed as "the world’s premier nephrology meeting," Kidney Week provides participants "exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field."

Conference Coverages

More Intensive Blood Pressure Goals Reserved for Most Severe Kidney Disease: KDIGO
More Intensive Blood Pressure Goals Reserved for Most Severe Kidney Disease: KDIGO
Recent updates by the 8th Joint National Committee (JNC 8), the American and International Societies of Hypertension (ASH-ISH), and KDIGO recommend target blood pressure of less than 140/90 mm Hg for most individuals, including those with CKD.
Updated Blood Pressure Guidelines from Major Bodies Agree on Targets in Kidney Disease
Two major sets of hypertension guidelines released in 2014 contain more common threads than differences, and are intended to serve different purposes. Clinicians seeking guidance for managing hypertension in chronic kidney disease (CKD) can look for this common ground to avoid "guideline overload."
Hypertension Guidelines Still Leave Room for Clinical Judgment
Guidelines for hypertension have converged on a blood pressure target of less than 140/90 mm Hg for most individuals with chronic kidney disease (CKD). However, studies still need to clarify optimal BPs for advanced disease and optimal cardiovascular prevention.
Making Improvements in Treating Kidney Disease VIDEO
In the past there were few effective treatment options for serious conditions such as hepatitis C and lupus. However, recent scientific advances offer physicians and patients greatly improved options for effective management of these conditions, with fewer adverse events.
Pharmacogenetics Helps Fine-Tune Warfarin Dosing in Kidney Disease
Though warfarin has long been the mainstay of anticoagulation in atrial fibrillation (AF), dosing is complicated by a host of factors, and the drug has a famously narrow therapeutic range. One way to fine-tune warfarin therapy is to account for genetic variation.
Gastric Bypass, Organ Transplants and the Future of Patient Care VIDEO
Obese patients present several challenges when it comes to gastric bypass, kidney transplant, and other surgeries. Several recent advances have reduced the risk of complications in this population.
Consider Individual Risks, Benefits for Anticoagulation in Chronic Kidney Disease
Anticoagulation is recommended for members of the general population with atrial fibrillation, but its significant risks must be weighed carefully in the medically fragile chronic kidney disease population.
Discussing the Ethics of Treating Ebola Patients VIDEO
There are many factors to consider when treating patients who may be infected with the Ebola virus, including several that are unique to the virus and that had not been widely considered prior to the current outbreak.
Atrial Fibrillation Associated with Accelerated Renal Disease; Ablation May Help
Treatment of atrial fibrillation (AF) in patients with CKD may help prevent disease progression. Ablation has been shown produce marked improvement in kidney function as measured by eGFR. A prospective study of individuals undergoing catheter ablation for AF showed that most patients remained AF-free, and that eGFR improved significantly for those with persistent or longstanding persistent AF.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$